Industry
View all stories with this category.
-
Business
Cleaning up clinical trials
Campaigns to enforce complete and correct reporting of trial data are beginning to take hold
-
Business
Novartis to cut over 2000 jobs
Move exemplifies a wave of manufacturing cuts as pharma moves to more high-value, specialised medicines
-
Opinion
Has Crispr’s patent battle run its course?
As the originators duke it out in court, their patents are becoming increasingly irrelevant
-
Business
‘No deal’ Brexit guidance fails to reassure UK chemical industry
UK government issues guidance on chemical regulation and patent law if the UK leaves the EU without agreement
-
-
Business
India moves to ban cocktail drugs
Government injunction on 328 fixed dose combinations is strongly opposed by manufacturers
-
-
Business
Landmark China cancer drug full approval ‘first of a wave’
Chi-Med’s fruquintinib is a result of China’s evolving drug innovation and regulation
-
Business
Building resilience to climate threats
As extreme weather events become more frequent, chemical and pharmaceutical producers are taking steps to fend them off in future
-
Research
Genentech antibiotic quells resistance
Modified arylomycin combines high potency with new mechanism of action